REJIMUS
  • SERVICES
    • BUSINESS RESOURCES
    • FACILITY DESIGN
    • FACILITY REGISTRATION
    • LITIGATION CONSULTING
    • RECALLS
    • REGULATORY SUPPORT
    • OUTSOURCING QA
    • SPECIFICATIONS
  • COMPLIANCE
    • 21 CFR PART 101
    • 21 CFR PART 111
    • 21 CFR PART 117
    • 21 CFR PART 501
    • 21 CFR PART 701
    • CPG SEC. 400.400
  • LABEL REVIEWS
    • ELR & CLR
    • CLAIMS SUBSTANTIATION
    • CLAIMSBAE™ DATABASE
  • NDI & GRAS
    • NDI SERVICES
    • GRAS SERVICES
    • CO-DEVELOPMENT PARTNERSHIP
  • TRAINING
  • CASE STUDIES
  • CONTACT
  • ABOUT
    • JOBS
    • RESOURCES
      • HELPFUL ARTICLES
    • NEWS AND MEDIA
      • NEWS
      • NEWSLETTERS
    • TEAM ARTICLES

Month: May 2020

Featured Image for covid-19 claims on dietary supplements

Dietary Supplements, Compliance, and COVID-19

Posted on by

Dietary Supplements, Compliance, and COVID-19 Tuesday, May 26, 2020Written by: Joel Villareal Dietary supplements and COVID-19? That is an interesting concept in the world today. With the current worldwide situation surrounding the pandemic, consumers alike are looking at various options to fight off a novel coronavirus, now named as COVID-19. It is a fact that[…]

Tagged Compliance, Covid-19, Dietary Supplement, FDA, Regulation

Posts navigation

RSS NutraIngredients

  • May Launch Pad May 30, 2023
  • Probiota Americas Day 1: CEOs, Postbiotics, and prebiotic crop breeding May 30, 2023
  • Cocoa and red berries may improve cardiovascular health in aging adults May 30, 2023

RSS WholeFoods

RSS NPI

  • BCAA formula blunts cyclists’ fatigue in time trial test May 30, 2023
  • FDA’s Birenbaum: Little known about ‘risk profile' of synthetic cannabinoids May 30, 2023
  • FDA official outlines ‘harm-reduction’ framework for CBD May 30, 2023
600 W. Santa Ana Blvd. Suite 1100 Santa Ana, CA 92701
info@rejimus.com
949 485 2112

REJIMUS™ 2023